Vaccine and Treatment Evaluation Unit:Phase II Pertussis Vaccine Trial

University Of Maryland Baltimore, Baltimore MD

Investigators

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.